Skip to main content

Rocklage Scott M's Form 4 filing

scPharmaceuticals Inc. (SCPH) · filed Oct 11, 2022

Accession no.
0001209191-22-053401
Filed
Oct 11, 2022, 7:10 PM ET
Trade date
Oct 6-10, 2022
Filing delay
5 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions. Open-market sales total $2.49M. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rocklage Scott MCIK 000121901410% Owner
Diekman John DCIK 000124035710% Owner
5AM Partners IV, LLCCIK 000158931410% Owner
5AM Ventures IV, L.P.CIK 000158931510% Owner
5AM Co-Investors IV, L.P.CIK 000159336110% Owner
Schwab Andrew J.CIK 000159854910% Owner
5AM Opportunities I, L.P.CIK 000175300010% Owner
5AM Opportunities I (GP), LLCCIK 000179077810% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 6, 2022Common StockSSaleDisposed−30,457$5.02−$152,894.142,688,014Indirect
Oct 6, 2022Common StockSSaleDisposed−1,269$5.02−$6,370.38112,000Indirect
Oct 6, 2022Common StockSSaleDisposed−5,808$5.02−$29,156.16497,304Indirect
Oct 10, 2022Common StockSSaleDisposed−456,413$4.09−$1,866,729.172,231,601Indirect
Oct 10, 2022Common StockSSaleDisposed−19,017$4.09−$77,779.5392,983Indirect
Oct 10, 2022Common StockSSaleDisposed−87,036$4.09−$355,977.24410,268Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)